by admin
Robert K. Gudbranson has been appointed to the position of senior vice president and chief financial officer. He rejoins Invacare after a stint at Lincoln Electric. He formally held the positions of Investor relations, business development director as well as being based in Europe where he was CFO.
March 7, 2008 No Comments
WASHINGTON - A Senate Finance Committee report released last week that outlines options for financing healthcare reform names HME reimbursement as a possible revenue source, but it doesn't propose specific cuts.
- #Prefilled syringes are replacing vials both in terms of injections and sector revenue, and as this trend continues during the next 4 years, the number of tailored injectable drug products reaching the market is set to escalate.
via Prefilled syringes proving popular - Pharm Tech Europe.
- #the investigators reported an anterior shift of less than 0.5 D of accommodation, which was disappointing in that patients were not spectacle-independent, according to Eduardo Marques, MD
- #FDA Approves Alcon's AcrySof(R) IQ ReSTOR(R) +3.0 D Intraocular Lens in the US. The product is already sold in Europe.
New Lens Corrects for Cataracts with Presbyopia
- #Advanced Medical Optics (AMO), Inc. and FDA notified healthcare professionals of a recall of Healon D Ophthalmic Viscosurgical Device, Lot Number UD30654, 30 mg/mL fill size syringes. Some of the tested OVD syringes had endotoxin levels above the required limit.
- #
Support open education with the Neoclassical Theme. Privacy.© 2004-2009 The International Medical Marketplace. All rights reserved. wordpress